Dennis M. Bleile
30Patents
9h-index
14Co-inventors
72Inventor score
Filing activity: Jun 18, 1982 → Jan 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4511662A | Simultaneous assay for T and B lymphocyte populations and subpopulations | Physics | 100 | Expired |
| US7765069B2 | Systems for the detection of short and long samples | Physics | 67 | Active |
| US4786594A | Enzyme immunoassay | Emerging Cross-Sectional Technologies | 36 | Expired |
| US7177767B2 | Systems and methods for the detection of short and long samples | Physics | 34 | Expired |
| US4448888A | Compositions and method for correcting temperature dependence of hemoglobin assays | Emerging Cross-Sectional Technologies | 22 | Expired |
| US9034656B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 12 | Active |
| US8758772B2 | Peptides and methods for the detection of lyme disease antibodies | Emerging Cross-Sectional Technologies | 10 | Active |
| US8828675B2 | Peptides, devices, and methods for the detection of ehrlichia antibodies | Emerging Cross-Sectional Technologies | 9 | Active |
| US8568989B2 | Peptides and methods for the detection of Lyme disease antibodies | Emerging Cross-Sectional Technologies | 9 | Active |
| US9921218B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 8 | Active |
| US9201071B2 | Peptides and methods for the detection of lyme disease antibodies | Emerging Cross-Sectional Technologies | 6 | Active |
| US10281465B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 5 | Active |
| US9157913B2 | Peptides, devices, and methods for the detection of Ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9696300B2 | Peptides, devices, and methods for the detection of ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9651546B2 | Peptides, devices, and methods for the detection of ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9442112B2 | Compositions and methods for identifying Ehrlichia species | Emerging Cross-Sectional Technologies | 4 | Active |
| US9470682B2 | Peptides, devices, and methods for the detection of Ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9851352B2 | Compositions and methods for identifying Ehrlichia species | Emerging Cross-Sectional Technologies | 3 | Active |
| US11255854B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 3 | Active |
| US9766238B2 | Peptides and methods for the detection of lyme disease antibodies | Emerging Cross-Sectional Technologies | 3 | Active |
| US9194870B2 | Peptides, devices, and methods for the detection of Anaplasma antibodies | Emerging Cross-Sectional Technologies | 3 | Active |
| US10444231B2 | Peptides, devices, and methods for the detection of Ehrlichia antibodies | Emerging Cross-Sectional Technologies | 2 | Active |
| US9702883B2 | Peptides, devices, and methods for the detection of anaplasma antibodies | Emerging Cross-Sectional Technologies | 2 | Active |
| US10073095B2 | Peptides and methods for the detection of lyme disease antibodies | Emerging Cross-Sectional Technologies | 2 | Active |
| US10330687B2 | Peptides, devices, and methods for the detection of anaplasma antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.